Enanta Pharmaceuticals is a clinical stage biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create ...
... Investors · Overview · Press Releases · Events & Presentations · Stock Information · Financials · ESG · Investor Resources · Contact Us. We've helped cure more ...
Senior Director of Investor Relations & Corporate Communications, N/A, N/A, N/A. Ms. Tara Lynn Kieffer Ph.D. Senior Vice President of New Product Strategy ...
Get the latest insights on Enanta Pharmaceuticals, Inc. Common Stock (ENTA) with press releases and corporate news to help you in your trading and investing ...
People also ask
How many employees does Enanta Pharmaceuticals have?
Enanta Pharmaceuticals, Inc. is currently listed on NASDAQ under ENTA. One share of ENTA stock can currently be purchased for approximately $14.00. Is Enanta ...
Missing: relations | Show results with:relations
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Feb 7, 2024 · (ENTA) Q1 2024 Earnings Call Transcript ... Investor Relations. Please go ahead ... High Yield Investor. About ENTA Stock. Symbol, Last Price, % Chg ...